![]() Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Refereed |
Title | Development and validation of a modified albumin-bilirubin grade and α-fetoprotein score (mALF score) for hepatocellular carcinoma patients receiving atezolizumab and bevacizumab. |
Journal | Formal name:Hepatology international ISSN code:19360541/19360533 |
Domestic / Foregin | Foregin |
Volume, Number, Page | pp.Online ahead of print. |
Papers・Author | Hatanaka Takeshi, Kakizaki Satoru, Hiraoka Atsushi, Tada Toshifumi, Hirooka Masashi, Kariyama Kazuya, Tani Joji, Atsukawa Masanori, Takaguchi Koichi, Itobayashi Ei, Fukunishi Shinya, Tsuji Kunihiro, Ishikawa Toru, Tajiri Kazuto, Ochi Hironori, Yasuda Satoshi, Toyoda Hidenori, Ogawa Chikara, Nishimura Takashi, Shimada Norihito, Kawata Kazuhiro, Kosaka Hisashi, Tanaka Takaaki, Ohama Hideko, Nouso Kazuhiro, Morishita Asahiro, Tsutsui Akemi, Nagano Takuya, Itokawa Norio, Okubo Tomomi, Arai Taeang, Imai Michitaka, Naganuma Atsushi, Koizumi Yohei, Nakamura Shinichiro, Kaibori Masaki, Iijima Hiroko, Hiasa Yoichi, Kumada Takashi |
Publication date | 2022/09 |